BeiGene to Present at 31st Annual J.P. Morgan Healthcare Conference in San Francisco
BEIGENE announced today John V. Oyler, Founder and Chief Executive Officer of BeiGene will present at 31st Annual J.P. Morgan Healthcare Conference from Jan 7-10th, 2013, at Westin St. Francis Hotel in San Francisco, California. John will give a talk during the China Track.
For further information, please contact: firstname.lastname@example.org
BeiGene is a Chinese life sciences biotechnology company based in the ZhongGuanCun Life Science Park in Beijing that is focused on discovering and developing innovative oncology drugs that encompass novel small molecules and biologics. BeiGene is pursuing this through its own internal discovery laboratories in China and by in-licensing from pharmaceutical partners’ investigational therapeutics that addresses unmet medical needs for Chinese and Asian patients with cancer. BeiGene is also creating a robust biomarkers and bioinformatics platform to enable the identification of specific subsets of patient populations who will most likely benefit from the use of specific drugs or treatments.
For more information, please visit www.beigene.com or contact email@example.com.